EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review)

Xiao Pang, Huai Liu, Ying Long, Hui Wang

International Journal of Oncology · 2025

DOI: 10.3892/ijo.2025.5834 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2025. Verfasst von Xiao Pang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South…. Hauptthemen laut MEDLINE: TOR Serine-Threonine Kinases, Lung Neoplasms, Radiation Tolerance, MTOR Inhibitors. Die Arbeit nennt 142 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Radiotherapy is an important treatment for tumors; however, some patients exhibit poor sensitivity to radiation, leading to unsatisfactory outcomes. mTOR regulates critical processes such as cell proliferation, autophagy and DNA repair, serving a central role in tumor biology. Moreover, mTOR inhibitors have shown potential to enhance radiotherapy effectiveness and address radiation resistance. Although drug resistance and side effects limit their clinical use, combining therapies and optimizing treatment plans could improve results. The present review summarizes how mTOR signaling contributes to radiation resistance in lung cancer, as well as the underlying molecular mechanisms. Understanding these pathways may aid the development of new combination therapies to improve treatment options for patients with lung cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TOR Serine-Threonine KinasesLung NeoplasmsRadiation ToleranceMTOR InhibitorsHumansSignal TransductionAutophagyDNA RepairCell Proliferation

Stichwörter der Autor:innen

lung cancermTORmTOR inhibitorradioresistanceresistance mechanisms

Substanzen

TOR Serine-Threonine KinasesMTOR protein, humanMTOR Inhibitors

Autor:innen und Institutionen

  • Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine/Hunan Cancer Hospital, Central South University, Changsha, Hunan 410013, P.R. China.

Zitieren

APA

Pang, X., Liu, H., Long, Y., & Wang, H. (2025). mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2025.5834

Vancouver

Pang X, Liu H, Long Y, Wang H. mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review). International Journal of Oncology. 2025. doi:10.3892/ijo.2025.5834

BibTeX
@article{Pang2025,
  author = {Pang, Xiao and Liu, Huai and Long, Ying and Wang, Hui},
  title = {mTOR in radiotherapy of lung cancer: Mechanisms of radiation resistance and therapeutic implications (Review)},
  journal = {International Journal of Oncology},
  year = {2025},
  doi = {10.3892/ijo.2025.5834}
}
Kostenlos starten →